- KR₩1tn
- KR₩1tn
- KR₩229bn
- 80
- 11
- 75
- 59
Annual balance sheet for Medy Tox, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 55,614 | 81,927 | 26,208 | 33,345 | 59,515 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 42,166 | 43,557 | 53,303 | 67,508 | 56,826 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 138,711 | 160,959 | 135,134 | 166,232 | 186,568 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 214,007 | 205,531 | 208,878 | 205,262 | 200,270 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 467,764 | 577,698 | 596,288 | 611,623 | 615,163 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 117,590 | 107,947 | 135,262 | 126,556 | 117,553 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 226,367 | 178,217 | 168,244 | 142,160 | 148,687 |
Redeemable Preferred Stock | |||||
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 241,398 | 399,481 | 428,045 | 469,463 | 466,476 |
Total Liabilities & Shareholders' Equity | 467,764 | 577,698 | 596,288 | 611,623 | 615,163 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |